July 29, 2008
Vanda shares dive 73% to 90 after FDA rejects drug
Shares of Vanda Pharmaceuticals fell 73 percent yesterday to its lowest level since going public two years ago after the Rockville company said the U.S. Food and Drug Administration rejected its schizophrenia …
From Insomnia News
Cat: | Time: 2:02 pm